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Management of critically ill patients in the intensive care
unit (ICU) is an important issue in medicine [1,2]. These
patients may have clinically important bleeding, which is
associated with an increased mortality rate. Mechanical
ventilation may also increase the risk of bleeding in the
upper gastrointestinal system. Sucralfate, histamine-2-
receptor antagonists, and proton pumps inhibitors (PPIs)
are widely used for stress ulcer prophylaxis in critically
ill adults [3]. Available data shows that PPIs are safe and
efficacious for increasing intragastric pH in critically ill
patients [4]. Since the superiority of the PPIs over
histamine-2-receptor antagonists or sucralfate is not yet
proved, they should only be used as an alternative to
these agents.
Poisoned patients may need to be admitted in ICU be-
cause of their critical condition. Poisoning with fatal
agents such as aluminum phosphide, paraquat, organo-
phosphate, or massive pharmaceutical drug overdoses
usually needs ICU care and sometimes mechanical ven-
tilation [5,6]. A question is therefore arisen: which of
these agents is better to be used for ulcer prophylaxis in
poisoned patients?
Affection of the cytochrome P450 (CYP) by toxins or
pharmaceutical drugs is an important point in answering
this question. Generally, most of the toxicants have a
liver metabolism [7]. The number of the known P450
enzyme inducers or inhibitors exceeds 1000, but P450
3A4 is the most frequent CYP in the human liver and is
known to metabolize the majority of drugs whose bio-
transformation is known [8]. So, inhibition or induction
of CYP may increase or decrease the final metabolites of
the toxicants and may have a value in the treatment of
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reproduction in any medium, provided the orHistamine-2-receptor antagonists are known as CYP
inhibitors [9] and PPIs are inducers of CYP [8]. PPIs can
therefore be recommended for the intoxications in
which a CYP inhibitor is involved (such as antidepres-
sant intoxication) or the medications which are toxic in
origin but induce non-toxic metabolites. Histamine-2 re-
ceptor antagonists may be more useful in the poisonings
with CYP inducers (such as carbamazepine or Phenobar-
bital toxicities) or in cases whose metabolits are more
toxic than the parent medication (such as acetamino-
phen, tramadol, etc.). This may affect the patients’ prog-
nosis as well as their hospital stay. We, therefore, would
like to encourage toxicologists to provide studies to
evaluate such potential benefits of each type of these
ulcer protectors in each poisoning.
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